PEPCID RPD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pepcid Rpd, and when can generic versions of Pepcid Rpd launch?
Pepcid Rpd is a drug marketed by Merck and is included in one NDA.
The generic ingredient in PEPCID RPD is famotidine. There are eighteen drug master file entries for this compound. One hundred and thirty-seven suppliers are listed for this compound. Additional details are available on the famotidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pepcid Rpd
A generic version of PEPCID RPD was approved as famotidine by FRESENIUS KABI USA on April 16th, 2001.
Summary for PEPCID RPD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Clinical Trials: | 35 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PEPCID RPD at DailyMed |
Recent Clinical Trials for PEPCID RPD
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University Comprehensive Cancer Center | Phase 2/Phase 3 |
Leidos Life Sciences | Phase 2 |
United States Department of Defense | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for PEPCID RPD
US Patents and Regulatory Information for PEPCID RPD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-001 | May 28, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-002 | May 28, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PEPCID RPD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-002 | May 28, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-001 | May 28, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-001 | May 28, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PEPCID RPD
See the table below for patents covering PEPCID RPD around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Italy | 1119641 | COMPOSTI DEL GUANIDINOTIAZOLO PARTICOLARMENTE UTILI COME ANTISECRETIVI GASTRICI E PROCEDIMENTO PER LA LORO PREPARAZIONE | ⤷ Try a Trial |
Switzerland | 648027 | GUANIDINOTHIAZOLVERBINDUNGEN, VERFAHREN ZU DEREN HERSTELLUNG UND ARZNEIMITTELZUBEREITUNGEN. | ⤷ Try a Trial |
Australia | 534329 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |